APA (7th ed.) Citation

EJ, H., X, C., B, M., J, B., Z, S., Z, L., & YX, F. (2021). A cytokine receptor-masked IL2 prodrug selectively activates tumor-infiltrating lymphocytes for potent antitumor therapy. Nature communications, 12(1), 2768. https://doi.org/10.1038/s41467-021-22980-w

Chicago Style (17th ed.) Citation

EJ, Hsu, Cao X, Moon B, Bae J, Sun Z, Liu Z, and Fu YX. "A Cytokine Receptor-masked IL2 Prodrug Selectively Activates Tumor-infiltrating Lymphocytes for Potent Antitumor Therapy." Nature Communications 12, no. 1 (2021): 2768. https://doi.org/10.1038/s41467-021-22980-w.

MLA (9th ed.) Citation

EJ, Hsu, et al. "A Cytokine Receptor-masked IL2 Prodrug Selectively Activates Tumor-infiltrating Lymphocytes for Potent Antitumor Therapy." Nature Communications, vol. 12, no. 1, 2021, p. 2768, https://doi.org/10.1038/s41467-021-22980-w.